BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36748382)

  • 1. Influencing factors and risk prediction model for cervical cancer recurrence.
    Li J; Luo J; Liu G; Yan S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1711-1720. PubMed ID: 36748382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
    Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
    BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.
    Li J; Liu G; Luo J; Yan S; Ye P; Wang J; Luo M
    Sci Rep; 2022 Aug; 12(1):13994. PubMed ID: 35978078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
    Liu J; Li S; Cao Q; Zhang Y; Nickel MD; Zhu J; Cheng J
    Ann Surg Oncol; 2023 Sep; 30(9):5577-5585. PubMed ID: 37355522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer.
    Deng C; Ding D; Wang M
    Postgrad Med; 2021 May; 133(4):436-443. PubMed ID: 33620285
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
    Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
    Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 12. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
    Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
    Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
    Cancer Res Treat; 2020 Jan; 52(1):320-333. PubMed ID: 31401822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients: A Retrospective Multicenter Study in mainland China.
    Meng T; Huang R; Hu P; Yin H; Lin S; Qiao S; Wang R; Wang J; Cai Z; Huang Z; Cheng L; Song D
    Spine (Phila Pa 1976); 2021 Jan; 46(1):E37-E47. PubMed ID: 32991511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
    Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective survey of influencing factors on patient survival without local recurrence and total survival in patients with early cervical cancer.
    Wen X; Lu W; Chen Y; Liao B
    J Pak Med Assoc; 2020 Sep; 70 [Special Issue](9):110-114. PubMed ID: 33177738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
    Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study.
    Shen Z; Xie L; Chen T; Tian D; Liu X; Xu H; Zhang Y; Wu Z; Sha N; Xing C; Ding N; Hu H; Wu C
    Medicine (Baltimore); 2016 Feb; 95(5):e2625. PubMed ID: 26844474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.